New insight from the interplay between nitric oxide and glucocorticoids

Critical Care Medicine

Volumn 32, Issue 11, 2004, Pages 2362-2363

  Suzuki, Hisanori ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Glucocorticoids; Glucocorticoids receptor; Inflammation; Lipopolysaccharides; Nitric oxide; Nitric oxide synthase

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; CATALYSIS; CONTROLLED STUDY; EDITORIAL; ENDOTOXEMIA; ENZYME INHIBITION; GENE EXPRESSION; INFLAMMATION; LOW DRUG DOSE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CRITICAL CARE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; SHOCK, SEPTIC;

EID: 8544267235     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000145955.88546.F7     Document Type: Editorial

References (13)

1. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a micro-vascular disorder: The role of constitutive nitric oxide. Brain Res Brain Res Rev 2000; 34:119-136
2. Colasanti M, Suzuki H: The dual personality of NO. Trends Pharmacol Sci 2000; 21: 249-252
3. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142
4. Colasanti M, Persichini T, Menegazzi M, et al: Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J Biol Chem 1995; 279:26731-26733
5. Brandtzaeg P: Significance and pathogenesis of septic shock. Curr Top Microbiol Immunol 1996; 216:15-37
6. Cohen J, Glauser MP: Septic shock: Treatment. Lancet 1991; 12:S68-S72
7. Robbins RA, Springall DR, Warren JB, et al: Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 1994; 198:835-843
8. Mariotto S, Menegazzi M, Suzuki H: Biochemical aspects of nitric oxide. Curr Pharm Des 2004; 10:1627-1645
9. Duma D, Silva-Santos JE, Assreuy J: Inhibition of glucocorticoid receptor binding by nitric oxide in endotoxemic rats. Crit Care Med 2004; 32:2304-2310
10. Stamler JS, Lamas S, Fang FC: Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001; 106:675-683
11. Matthews JR, Botting CH, Panico M, et al: Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 1996; 24: 2236-2242
12. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48-57
13. Rees DD, Cellek S, Palmer RM, et al: Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173:541-547